Tsumura & Co banner

Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 3 703 JPY 0.41% Market Closed
Market Cap: ¥284.2B

Tsumura & Co
Net Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tsumura & Co
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Tsumura & Co
TSE:4540
Net Income
¥40.8B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income
¥113.2B
CAGR 3-Years
-26%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Net Income
¥350.6B
CAGR 3-Years
67%
CAGR 5-Years
34%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Net Income
¥468B
CAGR 3-Years
39%
CAGR 5-Years
20%
CAGR 10-Years
12%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income
¥434B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Income
¥389.1B
CAGR 3-Years
32%
CAGR 5-Years
18%
CAGR 10-Years
4%
No Stocks Found

Tsumura & Co
Glance View

Market Cap
284.2B JPY
Industry
Pharmaceuticals

Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare. In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.

Intrinsic Value
3 472.39 JPY
Overvaluation 6%
Intrinsic Value
Price ¥3 703

See Also

What is Tsumura & Co's Net Income?
Net Income
40.8B JPY

Based on the financial report for Dec 31, 2025, Tsumura & Co's Net Income amounts to 40.8B JPY.

What is Tsumura & Co's Net Income growth rate?
Net Income CAGR 10Y
8%

Over the last year, the Net Income growth was 5%. The average annual Net Income growth rates for Tsumura & Co have been 16% over the past three years , 15% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett